| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/INTIMM/DXU087 |
| P698 | PubMed publication ID | 25239131 |
| P2093 | author name string | Atsushi Kumanogoh | |
| Tatsuaki Tsuruyama | |||
| Nobuyuki Fukuishi | |||
| Hironori Haga | |||
| Chiyuki Ueshima | |||
| Masahiro Hirata | |||
| Tatsuki R Kataoka | |||
| Koki Moriyoshi | |||
| P2860 | cites work | CD40 AND CD154 IN CELL-MEDIATED IMMUNITY | Q22255634 |
| CD72 negatively regulates KIT-mediated responses in human mast cells | Q24297400 | ||
| Development, migration, and survival of mast cells | Q24549674 | ||
| Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors | Q28118852 | ||
| Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses | Q28189775 | ||
| Of mice and not men: differences between mouse and human immunology | Q28246229 | ||
| RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells | Q28586055 | ||
| Identification of CD72 as a Lymphocyte Receptor for the Class IV Semaphorin CD100 | Q29036802 | ||
| Mast cell-T cell interactions | Q33731155 | ||
| Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder | Q33784323 | ||
| Aggregation of the high-affinity IgE receptor and enhanced activity of p53/56lyn protein-tyrosine kinase | Q35903919 | ||
| Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk. | Q36370786 | ||
| Integrated signalling pathways for mast-cell activation | Q36392833 | ||
| Mast cells and mastocytosis | Q36835143 | ||
| Activation and function of the mTORC1 pathway in mast cells | Q37233311 | ||
| Amplification mechanisms for the enhancement of antigen-mediated mast cell activation | Q37259631 | ||
| Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment | Q37316086 | ||
| Modulation of peripheral B cell tolerance by CD72 in a murine model | Q37465464 | ||
| AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit. | Q39726849 | ||
| B-cell co-receptor CD72 is expressed on NK cells and inhibits IFN-gamma production but not cytotoxicity | Q39886814 | ||
| Stromal-cell-derived factor-1/CXCL12-induced chemotaxis of a T cell line involves intracellular signaling through Cbl and Cbl-b and their regulation by Src kinases and CD45. | Q40311183 | ||
| Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl). | Q40524623 | ||
| The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1. | Q41008340 | ||
| Inhibitory receptors, ITIM sequences and phosphatases | Q41514609 | ||
| Activation of B lymphocytes by monovalent anti-Lyb-2 antibodies | Q42273163 | ||
| CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function | Q46208076 | ||
| Dual regulation of BCR-mediated growth inhibition signaling by CD72. | Q46426359 | ||
| P433 | issue | 2 | |
| P921 | main subject | mast cell | Q191989 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 95-103 | |
| P577 | publication date | 2014-09-19 | |
| P1433 | published in | International Immunology | Q15710043 |
| P1476 | title | CD72 negatively regulates mouse mast cell functions and down-regulates the expression of KIT and FcεRIα. | |
| P478 | volume | 27 |
Search more.